anonymous
Guest
anonymous
Guest
Tons of reports, from providers, of overly aggressive Ingrezza reps. Especially in LTC. One provider claimed the Ingrezza rep sifted through PI and charts, circling which names to switch from Cogentin to Ingrezza. Going to be a dark day for Neurocrine soon..